The Impact of CBD Data Gaps on Novel Food Applications

EFSA has highlighted a range of toxicological concerns regarding CBD and published new data requirements that must be fulfilled for successful Novel Food Applications. This presentation will discuss the insufficiencies highlighted by EFSA relating to the current body of data and offer potential strategies that applicants of paused and future Novel Food evaluations could consider to successfully gain access to the European market.